[Autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma with severe renal impairment: a report of 5 cases and literature review]

Zhonghua Xue Ye Xue Za Zhi. 2023 Jul 14;44(7):587-589. doi: 10.3760/cma.j.issn.0253-2727.2023.07.012.

[Article in Chinese]

Authors

Y Lu¹, G N Shi¹, S Z Yuan¹, X B Xiao¹, X L Chen¹, Y Ma¹, S H Zhao¹, J L Chen¹, X L Zhang¹, Y Q Wang¹, W R Huang¹

Affiliation

¹ Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.

PMID: 37749041
PMCID: PMC10509614
DOI: 10.3760/cma.j.issn.0253-2727.2023.07.012

No abstract available

Publication types

Review
Case Reports

MeSH terms

Bortezomib
Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma* / diagnosis
Multiple Myeloma* / therapy
Stem Cell Transplantation
Transplantation, Autologous

Substances

Bortezomib